Kutub Mahmood

Dr. Mahmood is the scientific director of the polio vaccine development project, at the nonprofit organization PATH, based in Seattle, Washington. The polio vaccine project is part of PATH's broader effort to develop low-cost vaccine supplies for the global markets. Dr. Mahmood focuses primarily on conducting technical assessment for vaccine manufacturers and providing support to help them achieve who pre-qualification for their vaccine products. He also works to identify potential partnerships with multinational pharmaceutical companies, biotech firms, and public/private enterprises. He joined PATH in March 2012 after 20 years leading vaccine discovery and product development efforts in private industry, with stints at Medimmune, Novavax, and other start-up vaccine companies including Vivaldi Biosciences. Dr. Mahmood made numerous contributions to the successful development of the Flumist®, a live attenuated influenza vaccine.